| Systematic (IUPAC) name | |
|---|---|
(RS)-1-(Isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol | |
| Clinical data | |
| Pronunciation | /mɛˈtoʊproʊlɑːl/, /mɛtoʊˈproʊlɑːl/ |
| Trade names | Lopressor, Metolar XR |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a682864 |
| License data |
|
| Pregnancy category |
|
| Routes of administration | By mouth, IV |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Bioavailability | 50%[1] |
| Protein binding | 12% |
| Metabolism | Liver via CYP2D6, CYP3A4 |
| Biological half-life | 3-7 hours |
| Excretion | Kidney |
| Identifiers | |
| CAS Number | 51384-51-1 |
| ATC code | C07AB02 (WHO) |
| PubChem | CID 4171 |
| IUPHAR/BPS | 553 |
| DrugBank | DB00264 |
| ChemSpider | 4027 |
| UNII | GEB06NHM23 |
| KEGG | D02358 |
| ChEBI | CHEBI:6904 |
| ChEMBL | CHEMBL13 |
| Chemical data | |
| Formula | C15H25NO3 |
| Molar mass | 267.364 g/mol g·mol−1 |
| Chirality | Racemic mixture |
| |
| |
| Physical data | |
| Melting point | 120 °C (248 °F) |
| (verify) | |
- ↑ "Metolar 25/50 (metoprolol tartrate) tablet" (PDF). FDA. Retrieved 5 May 2015.